A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the Radiation Therapy Oncology Group (RTOG) 9104

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 3, 1997, Pages 571-574

  Murray, Kevin J ^a   Scott, Charles ⁱ   Greenberg, Harvey M ^b   Emami, Bahman ^c   Seider, Michael ^d   Vora, Nayana L ^e   Olson, Craig ^f   Whitton, Anthony ^j   Movsas, Benjamin ^g   Curran, Walter ^h  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d SUMMA HEALTH SYSTEM   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f EAST CAROLINA UNIVERSITY   (United States)

^g FOX CHASE CANCER CENTER   (United States)

^h Bodine Center for Cancer Treatment   (United States)

ⁱ RTOG Headquarters   (United States)

^j Department of Radiation Oncology ^*

more..

Author keywords

Brain metastases; Hyperfractionation; Radiation therapy

Indexed keywords

ACCELERATED HYPERFRACTIONATED RADIOTHERAPY; ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RADIATION INJURIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 18744420820     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00341-6     Document Type: Article

References (6)

1. Borgelt, B.; Gelber, R.; Cramer, S.; Brady, L. W.; Chang, C.H.; Davis, L.W.; Perez, C.A.; Hendrickson, F.R. The palliation of brain metastasis: Final results of the first two studies by the Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 6:1-9; 1980.
2. Borgelt, B.; Gelber, R.; Larson, M.; et al. Ultra rapid high dose irradiation schedules for the palliation of brain metastasis: Final results of the first two studies by the Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 7:1633-1638; 1981.
3. D'elia, F.; Bonucci, I.; Biti, G. P.; Pirtoli, L. Different fractionation schedules in radiation treatment of cerebral metastases. Acta Radiol. Oncol. 25:181-184; 1986.
4. Epstein, B. E.; Scott, C. B.; Sause, W.T.; Rotman, M.; Sneed, P. K.; Janjan, N. A.; Davis, L. W.; Selim, H.; Mohiuddin, M.; Wasserman, T. H.; Curran, W. J., Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionation radiation therapy at total doses of 54.4 Gy and greater; results of Radiation Therapy Oncology Group 85-28. Cancer 71:1362-1367; 1993.
5. Prentice, R. L.; Marek, P. A qualitative discrepancy between censored data rank tests. Biometrics 35:861-867; 1979.
6. Sause, W. T.; Scott, C. B.; Krisch, R.; Rotman, M.; Sneed, P. K.; Janjan, N. A.; Davis, L. W.; Curran, W. J.; Coi, K. N.; Selim, H.; Mohiuddin, M.; Grigsby, P. Phase I/II trail of accelerated fractionation in brain metastasis. RTOG 85-28 Int. J. Radiat. Oncol. Biol. Phys. 26:653-657; 1993.